Pearl River Capital, LLC Lantheus Holdings, Inc. Transaction History

Pearl River Capital, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$58.87 - $83.05 $601,180 - $848,106	-10,212 Reduced 22.88%	34,415 $2.76 Million
Q1 2024 May 14, 2024	BUY	$51.07 - $68.26 $988,204 - $1.32 Million	19,350 Added 76.55%	44,627 $2.78 Million
Q4 2023 Feb 13, 2024	BUY	$55.6 - $77.89 $446,801 - $625,924	8,036 Added 46.61%	25,277 $1.57 Million
Q3 2023 Nov 13, 2023	SELL	$60.27 - $90.75 $683,763 - $1.03 Million	-11,345 Reduced 39.69%	17,241 $1.2 Million
Q2 2023 Aug 11, 2023	BUY	$82.41 - $99.65 $735,426 - $889,276	8,924 Added 45.39%	28,586 $2.4 Million
Q1 2023 Dec 19, 2024	BUY	$47.76 - $82.86 $939,057 - $1.63 Million	19,662 New	19,662 $1.62 Million
Q1 2023 May 12, 2023	BUY	$47.76 - $82.86 $83,150 - $144,259	1,741 Added 9.71%	19,662 $1.62 Million
Q4 2022 Feb 13, 2023	BUY	$48.76 - $77.67 $79,235 - $126,213	1,625 Added 9.97%	17,921 $913,000
Q3 2022 Nov 14, 2022	BUY	$61.42 - $86.29 $341,372 - $479,599	5,558 Added 51.76%	16,296 $1.15 Million
Q2 2022 Aug 12, 2022	BUY	$55.54 - $72.65 $369,618 - $483,485	6,655 Added 162.99%	10,738 $709,000
Q1 2022 May 13, 2022	BUY	$24.28 - $56.64 $99,135 - $231,261	4,083 New	4,083 $226,000

532

73M

598K

371K

Ticker LNTH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 68,741,904
Market Cap $6.67B
Description
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...

Get notified when there are updates to the investment portfolio of Pearl River Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Pearl River Capital, LLC with notifications on news.